Pure Global

Cryogenic spray, cutaneous

Access comprehensive regulatory information for Cryogenic spray, cutaneous in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Orion Laboratories Pty Ltd T/A Perrigo Australia, manufactured by Omega Pharma International NV in Belgium. The device registration started on December 16, 2015.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIa
Class IIa
Cryogenic spray, cutaneous
Australia TGA ARTG Registered Device
Good Name: Orion Laboratories Pty Ltd T/A Perrigo Australia - Cryogenic spray, cutaneous
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

To indirectly freeze warts, plantar warts or verrucas by cooling an applicator which is applied to the skin causing the formation of a blister beneath the skin and the wart or verruca to fall off after a number of days whilst new skin is formed underneath the blister.

Device Classification
Risk Class
Class IIa
Product Type
Single Device Product
ARTG Category
General
Registration Information
Start Date
December 16, 2015
Effective Date
December 16, 2015
Manufacturer
Country
Belgium
Address
Venecoweg 26, Nazareth, B-9810